Excitation-contraction coupling of human induced pluripotent stem cell-derived cardiomyocytes.
Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) hold enormous potential in many fields of cardiovascular research. Overcoming many of the limitations of their embryonic counterparts, the application of iPSC-CMs ranges from facilitating investigation of familial cardiac disease and pharmacological toxicity screening to personalized medicine and autologous cardiac cell therapies. The main factor preventing the full realization of this potential is the limited maturity of iPSC-CMs, which display a number of substantial differences in comparison to adult cardiomyocytes. Excitation-contraction (EC) coupling, a fundamental property of cardiomyocytes, is often described in iPSC-CMs as being more analogous to neonatal than adult cardiomyocytes. With Ca(2+) handling linked, directly or indirectly, to almost all other properties of cardiomyocytes, a solid understanding of this process will be crucial to fully realizing the potential of this technology. Here, we discuss the implications of differences in EC coupling when considering the potential applications of human iPSC-CMs in a number of areas as well as detailing the current understanding of this fundamental process in these cells.
Laboratory of Cell Electrophysiology, National Heart and Lung Institute, Imperial College London London, UK.
Christopher
C
Kane
Laboratory of Cell Electrophysiology, National Heart and Lung Institute, Imperial College London London, UK.
Liam
L
Couch
Laboratory of Cell Electrophysiology, National Heart and Lung Institute, Imperial College London London, UK.
Cesare M N
CM
Terracciano
disease modeling; excitation–contraction coupling; induced pluripotent stem cell-derived cardiomyocytes; pharmacological screening; stem cell maturation